ARCHIVES

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

OPR Reinstates Duke Medical Center’s License To Conduct Human Studies

May 28, 1999

Finasteride Could Save Many Years Of Life If Widely Used For Prostate Cancer Prevention

February 25, 2005

In Brief: Wittes to Join Bristol-Myers As VP; Friedman Named Acting CTEP Director; Carl Pinsky Leaves

September 23, 1988

Estrogen Alone Didn’t Increase Lung Cancer Mortality In WHI

August 27, 2010

IOM Finds Asbestos Causes Cancer of the Larynx.

June 16, 2006

Fifty-Nine CCOP Awards Made; Payline 250, Six Funded as Exceptions

May 27, 1983